Erythropoietin disrupts hypoxia-inducible factor signaling in ovarian cancer cells

Folkman, 2000, Incipient angiogenesis, J. Natl. Cancer Inst., 92, 94, 10.1093/jnci/92.2.94 Semenza, 2000, HIF-1: using two hands to flip the angiogenic switch, Cancer Metastasis Rev., 19, 59, 10.1023/A:1026544214667 Rofstad, 2000, Microenvironment-induced cancer metastasis, Int. J. Radiat. Biol., 76, 589, 10.1080/095530000138259 Semenza, 2000, HIF-1: mediator of physiological and pathophysiological responses to hypoxia, J. Appl. Physiol., 88, 1474, 10.1152/jappl.2000.88.4.1474 Lee, 2004, Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions, Exp. Mol. Med., 36, 1, 10.1038/emm.2004.1 Semenza, 2003, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer, 3, 721, 10.1038/nrc1187 Wong, 2003, VEGF and HIF-1a expression are increased in advanced stages of epithelial ovarian cancer, Gynecol. Oncol., 91, 513, 10.1016/j.ygyno.2003.08.022 Fisher, 2003, Erythropoietin: physiology and pharmacology update, Exp. Biol. Med. (Maywood), 228, 1, 10.1177/153537020322800101 Ribatti, 1999, Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo, Blood, 93, 2627, 10.1182/blood.V93.8.2627 Stevenson, 2001, Membrane depolarization mediates phosphorylation and nuclear translocation of CREB in vascular smooth muscle cells, Exp. Cell Res., 263, 118, 10.1006/excr.2000.5107 Wellman, 2004, Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia-inducible factor-1alpha (HIF-1alpha) in explants of human pial arteries, FASEB J., 18, 379, 10.1096/fj.03-0143fje Dong, 2004, Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling, Cancer Res., 64, 19, 10.1158/0008-5472.CAN-03-2789 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 Lounsbury, 1994, A family of proteins that stabilize the Ran/TC4 GTPase in its GTP-bound conformation, J. Biol. Chem., 269, 11285, 10.1016/S0021-9258(19)78123-X Brahimi-Horn, 2005, Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications, Cell Signal, 17, 1, 10.1016/j.cellsig.2004.04.010 Forsythe, 1996, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor-1, Mol. Cell. Biol., 16, 4604, 10.1128/MCB.16.9.4604 Shweiki, 1992, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis, Nature, 359, 843, 10.1038/359843a0 Acs, 2001, Erythropoietin and erythropoietin receptor expression in human cancer, Cancer Res., 61, 3561 Yasuda, 2003, Erythropoietin regulates tumour growth of human malignancies, Carcinogenesis, 24, 1021, 10.1093/carcin/bgg060 Farrell, 2004, The erythropoietin receptor and its expression in tumor cells and other tissues, Oncologist, 9, 18, 10.1634/theoncologist.9-90005-18 Zhong, 2000, Modulation of hypoxia-inducible factor 1 expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics, Cancer Res., 60, 1541 Jung, 2003, IL-1 beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis, FASEB J., 14, 2115, 10.1096/fj.03-0329fje Feldser, 1999, Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2, Cancer Res., 59, 3915 Kallio, 1999, Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway, J. Biol. Chem., 274, 6519, 10.1074/jbc.274.10.6519 Alfranca, 2002, c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription, Mol. Cell. Biol., 22, 12, 10.1128/MCB.22.1.12-22.2002 Mizukami, 2004, Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer, Cancer Res., 64, 1765, 10.1158/0008-5472.CAN-03-3017 Santos, 2001, Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway, Oncogene, 20, 2080, 10.1038/sj.onc.1204308 Schmaltz, 1998, Regulation of proliferation-survival decisions during tumor cell hypoxia, Mol. Cell. Biol., 18, 2845, 10.1128/MCB.18.5.2845 Littlewood, 2001, Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trail, J. Clin. Oncol., 9, 2865, 10.1200/JCO.2001.19.11.2865 Mittelman, 2004, Erythropoietin has an anti-myeloma effect—A hypothesis based on a clinical observation supported by animal studies, Eur. J. Haematol., 72, 155, 10.1046/j.0902-4441.2003.00190.x Acs, 2004, Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells, Cancer Lett., 214, 243, 10.1016/j.canlet.2004.04.027 Silver, 1999, Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effect, Gynecol. Oncol., 73, 280, 10.1006/gyno.1999.5368